Eledon Pharmaceuticals (ELDN) Stock Price
$4.29 0%
to add to portfolio
AI Score
-
Alternative
10 -
Fundamental
2 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Eledon Pharmaceuticals, AI stock picks, stock alerts and much more.
ELDN AI Stock Analysis
AI stock analysis for ELDN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Eledon Pharmaceuticals (ELDN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Eledon Pharmaceuticals (ELDN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Eledon Pharmaceuticals (ELDN), currently trading at $4.29, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ELDN
-
Eledon Pharmaceuticals, Inc.
-
Symbol
ELDN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
256.3M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
ELDN Alternative Data
Web Traffic
Eledon Pharmaceuticals receives an estimated 9637 monthly visitors to eledon.com.
-
Web Traffic
9637
-
Change from Previous Month
34.7%
-
3 Month Change
122.7%
-
YoY Change
122.7%
News Mentions
Eledon Pharmaceuticals was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Eledon Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Eledon Pharmaceuticals has 211 Twitter Followers on its main Twitter (also known as X) account, which is up by 3.4% over the last month.
-
Twitter Followers
211
-
Daily Change
0%
-
1 Month Change
3.4%
-
3 Month Change
0.5%
LinkedIn Followers
2,897 are following Eledon Pharmaceuticals on LinkedIn, up by 5.6% over the last month.
-
LinkedIn Followers
2897
-
Daily Change
0.1%
-
1 Month Change
5.6%
-
3 Month Change
10.9%
Job Postings
Eledon Pharmaceuticals has an estimated 0 open job postings, which is down -100% over the last month.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Eledon Pharmaceuticals has 33 employees, up by 6.5% over the last month.
-
LinkedIn Employees
33
-
Daily Change
0%
-
1 Month Change
6.5%
-
3 Month Change
13.8%
ELDN Financials
ELDN Key Metrics
-
Total Revenue
$0
-
Net Income
$77M
-
Earnings per Share
-$0.34
-
Free cash flow
-$11.8M
-
EBITDA
-$20.4M
-
EBITDA Ratio
0
-
Total Assets
$114.6M
ELDN 2-year Revenue & Income
ELDN 2-year Free Cash Flow
ELDN Technicals
ELDN SMA
ELDN RSI
FAQ
What's the current price of Eledon Pharmaceuticals (ELDN) Stock?
The price of an Eledon Pharmaceuticals (ELDN) share is $4.29.
What's the market cap of Eledon Pharmaceuticals?
The current market cap of Eledon Pharmaceuticals is 256.3M.
Should I buy or sell ELDN?
Eledon Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Eledon Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is Eledon Pharmaceuticals a good investment?
The current analysis of Eledon Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Eledon Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Eledon Pharmaceuticals (ELDN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Eledon Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Eledon Pharmaceuticals (ELDN) that investors often compare it to?
Eledon Pharmaceuticals (ELDN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Eledon Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Eledon Pharmaceuticals' stock price to be around $4.42 in 2026. Starting from the current price of $4.29, this represents a 3% change in price, indicating a neutral outlook for the stock.
How to buy Eledon Pharmaceuticals (ELDN) Stock?
Eledon Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Eledon Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.